MAM
AZN icon

Madison Asset Management’s AstraZeneca AZN Stock Holding History

Madison Asset Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.04M Sell
21,310
-126
-0.6% -$23.7K 0.05% 188
2026
Q1 		$4.23M Buy
21,436
+1,144
+6% +$221K 0.05% 178
2025
Q4 		$3.73M Sell
20,292
-798
-4% -$140K 0.04% 190
2025
Q3 		$3.24M Sell
21,090
-2,454
-10% -$371K 0.04% 195
2025
Q2 		$3.29M Sell
23,544
-388
-2% -$54.4K 0.04% 199
2025
Q1 		$3.52M Sell
23,932
-1,463
-6% -$212K 0.04% 191
2024
Q4 		$3.33M Sell
25,395
-1,860
-7% -$260K 0.04% 202
2024
Q3 		$4.25M Sell
27,255
-1,326
-5% -$214K 0.05% 182
2024
Q2 		$4.46M Sell
28,581
-1,311
-4% -$197K 0.06% 180
2024
Q1 		$4.05M Buy
29,892
+3,906
+15% +$517K 0.05% 196
2023
Q4 		$3.5M Sell
25,986
-682
-3% -$88.7K 0.05% 206
2023
Q3 		$3.61M Buy
26,668
+5
+0% +$683 0.05% 194
2023
Q2 		$3.82M Sell
26,663
-321
-1% -$47.2K 0.06% 193
2023
Q1 		$3.75M Sell
26,984
-211
-0.8% -$28.4K 0.06% 191
2022
Q4 		$3.69M Sell
27,195
-9,434
-26% -$1.18M 0.06% 193
2022
Q3 		$4.02M Buy
36,629
+2,788
+8% +$354K 0.07% 175
2022
Q2 		$4.47M Sell
33,841
-16,804
-33% -$2.2M 0.07% 170
2022
Q1 		$6.72M Sell
50,645
-462
-0.9% -$55.4K 0.1% 139
2021
Q4 		$5.95M Sell
51,107
-8,591
-14% -$1.01M 0.08% 167
2021
Q3 		$7.17M Buy
59,698
+8,497
+17% +$989K 0.1% 148
2021
Q2 		$6.13M Buy
51,201
+5,654
+12% +$620K 0.08% 168
2021
Q1 		$4.53M Buy
45,547
+6,715
+17% +$675K 0.06% 201
2020
Q4 		$3.88M Buy
+38,832
New +$4.11M 0.06% 207

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Madison Asset Management's AZN Position: Q2 2026 in Review

Madison Asset Management reduced its AstraZeneca (AZN) stake by 0.59% in Q2 2026, selling an estimated $23.7K and leaving 21,310 shares worth $4.04M. The position accounts for 0.05% of the portfolio, ranked #188.

Madison Asset Management first reported a position in AZN in Q4 2020 and has held it in 23 quarters since. The position peaked at $7.17M in Q3 2021. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Madison Asset Management held 21,310 shares of AstraZeneca worth $4.04M as of Q2 2026.
  • Madison Asset Management sold 126 AstraZeneca shares in Q2 2026, an estimated $23.7K.
  • AstraZeneca made up 0.05% of Madison Asset Management's portfolio in Q2 2026, its #188 holding.
  • Madison Asset Management first reported a position in AstraZeneca in Q4 2020 and has held it in 23 quarters since.
  • Madison Asset Management's AstraZeneca position peaked at $7.17M in Q3 2021.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Madison Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.